Equity Profile

CAI

Caris Life Sciences, Inc.

Health CareBiotechnology$4.7B

Feb15Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close9:00 AM EST

Company Snapshot

Caris Life Sciences, Inc. is a biotechnology company focused on precision medicine and genomic testing....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating revenue.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market share and sustain operations.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CAI Q2-2026 Earnings Preview

Context

Company Snapshot

Caris Life Sciences, Inc. is a biotechnology company focused on precision medicine and genomic testing. Operating in the health care sector, it aims to provide insights that help in the diagnosis and treatment of cancer, making it a significant player in personalized medicine.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+541.94%

Avg Stock Reaction

+1.24%

Last Quarter Recap

In the last quarter, Caris Life Sciences reported an earnings surprise of 100%, with EPS coming in at $0.00 compared to an estimate of $-0.02. The stock reacted positively, gaining 3.71% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as the company has shown a strong ability to beat earnings estimates in the past. However, the lack of analyst estimates for this quarter adds uncertainty.

Bull Case

If Caris continues its trend of beating EPS estimates, it could lead to increased investor confidence and a higher stock price.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for this quarter?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment.

What guidance will management provide for revenue growth?

Management's outlook on revenue growth will be key to understanding the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Caris's ability to maintain its earnings surprise streak, especially given its recent performance.

Supporting Evidence

Caris has consistently beaten EPS estimates in the last four quarters, indicating strong operational execution.

The options market is pricing in a larger move than the historical average, suggesting that traders expect significant news.

The lack of analyst estimates could mean that any positive surprise will have a larger impact on stock price.

Key Risk

If EPS comes in above $0.00, it could significantly shift market sentiment in favor of the company.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis this quarter revolves around Caris's ability to maintain its earnings momentum and provide credible guidance.

Bull Confirmed If

An EPS of $0.02 or higher would confirm the bull case and signal strong operational performance.

Bear Confirmed If

An EPS below $-0.02 would confirm the bear case and raise concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±7.61%

Historical Avg

±5.6%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±7.6% while CAI has averaged ±5.6% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

90.5%

Calls (60K)P/C Ratio: 0.04Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Caris beats expectations, history suggests the stock could rise by about 0.82% on the next trading day, confirming positive investor sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await more detailed commentary from management.

Miss

If the company misses expectations, history suggests a potential drop of around 6.32%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new partnerships or collaborations in precision medicine.
2Details on the company's pipeline and upcoming product launches.
3Management's commentary on market trends and competitive landscape.
4Insights into cost management and operational efficiency.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Scorpio Tankers Inc.

Company Snapshot

Caris Life Sciences, Inc. is a biotechnology company focused on precision medicine and genomic testing....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating revenue.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market share and sustain operations.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CAI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+541.94%

Avg Stock Reaction

+1.24%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations are mixed as the company has shown a strong ability to beat earnings estimates in the past. However, the lack of analyst estimates for this quarter adds uncertainty.

Bull Case

If Caris continues its trend of beating EPS estimates, it could lead to increased investor confidence and a higher stock price.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for this quarter?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment.

What guidance will management provide for revenue growth?

Management's outlook on revenue growth will be key to understanding the company's future performance and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Caris's ability to maintain its earnings surprise streak, especially given its recent performance.

Supporting Evidence

Caris has consistently beaten EPS estimates in the last four quarters, indicating strong operational execution.

The options market is pricing in a larger move than the historical average, suggesting that traders expect significant news.

The lack of analyst estimates could mean that any positive surprise will have a larger impact on stock price.

Key Risk

If EPS comes in above $0.00, it could significantly shift market sentiment in favor of the company.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis this quarter revolves around Caris's ability to maintain its earnings momentum and provide credible guidance.

Bull Confirmed If

An EPS of $0.02 or higher would confirm the bull case and signal strong operational performance.

Bear Confirmed If

An EPS below $-0.02 would confirm the bear case and raise concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±7.61%

Historical Avg

±5.6%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±7.6% while CAI has averaged ±5.6% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

90.5%

Calls (60K)P/C Ratio: 0.04Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Caris beats expectations, history suggests the stock could rise by about 0.82% on the next trading day, confirming positive investor sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await more detailed commentary from management.

Miss

If the company misses expectations, history suggests a potential drop of around 6.32%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new partnerships or collaborations in precision medicine.
2Details on the company's pipeline and upcoming product launches.
3Management's commentary on market trends and competitive landscape.
4Insights into cost management and operational efficiency.